News | April 28, 2022
Thermo Fisher Scientific expands R&D facility in Hyderabad
This facility will design & develop instruments, perform product reliability performance testing and verification
This facility will design & develop instruments, perform product reliability performance testing and verification
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Partnership with Modality, award-winning GP super partnership
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said
The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences
Supply increase to help meet growing global demand
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
The grants are expected to be received over the next three years, commencing March 2022
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Subscribe To Our Newsletter & Stay Updated
